Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Todd Neale

March 28, 2020

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

L.A. McKeown

June 30, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

CME

Advertisement

AHA Statement Outlines Cardiac Contributions to Brain Health

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Long-term Ticagrelor Therapy Cost-Effective in US Patients

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Aspirin for the Interventionalist: More Than Meets the Eye

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content